首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   92228篇
  免费   9024篇
  国内免费   4862篇
耳鼻咽喉   912篇
儿科学   1424篇
妇产科学   811篇
基础医学   9656篇
口腔科学   1432篇
临床医学   11097篇
内科学   12513篇
皮肤病学   1657篇
神经病学   4215篇
特种医学   3879篇
外国民族医学   29篇
外科学   8713篇
综合类   16319篇
现状与发展   19篇
一般理论   13篇
预防医学   8053篇
眼科学   2136篇
药学   10264篇
  115篇
中国医学   6217篇
肿瘤学   6640篇
  2024年   341篇
  2023年   1251篇
  2022年   3268篇
  2021年   4306篇
  2020年   3291篇
  2019年   2765篇
  2018年   2805篇
  2017年   3031篇
  2016年   3066篇
  2015年   4496篇
  2014年   5611篇
  2013年   6013篇
  2012年   8432篇
  2011年   8724篇
  2010年   6609篇
  2009年   5436篇
  2008年   6000篇
  2007年   5764篇
  2006年   5211篇
  2005年   4522篇
  2004年   3315篇
  2003年   3022篇
  2002年   2531篇
  2001年   1755篇
  2000年   1249篇
  1999年   793篇
  1998年   407篇
  1997年   426篇
  1996年   293篇
  1995年   231篇
  1994年   185篇
  1993年   134篇
  1992年   117篇
  1991年   123篇
  1990年   104篇
  1989年   100篇
  1988年   63篇
  1987年   58篇
  1986年   45篇
  1985年   46篇
  1984年   26篇
  1983年   23篇
  1982年   13篇
  1981年   16篇
  1980年   10篇
  1979年   25篇
  1978年   11篇
  1977年   10篇
  1976年   8篇
  1975年   7篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
目的:评估MDCT在术前耳硬化症诊断中的作用。方法:收集经临床证实为耳硬化症、且CT扫描采用螺旋扫描病例共18例,采集的数据传输到4.1工作站,进行多平面重建。结果:18例共36耳显示异常:单独前庭窗异常18耳,表现为前庭窗扩大或狭小,周围骨质密度降低或镫骨底板板密度增高;前庭窗及蜗窗同时受累共8耳;主要累及耳蜗周围迷路骨质10耳,表现为耳蜗骨迷路边缘不整,呈条片状密度减低或双环征。MPR交互重建充分显示了所有重要解剖结构的位置、形态:其中3耳为颈静脉球高位。结论:MDCT可以正确显示耳硬化症病灶的细微改变,提供详细的术前诊断信息;结合MPR技术可全面观察病变范围,并充分显示颞骨内重要解剖结构的位置和形态。对于手术方案的设计、防止手术并发症和提高疗效等具有重要意义。  相似文献   
72.
We report on the clinical and histological features of five cases of epithelioid trophoblastic tumor, with an emphasis on its involvement of the uterine cervix. All five patients were of reproductive age (median age 38.4 years) and all, except one, presented with vaginal bleeding 3 to 18 years after the most recent pregnancy. One patient presented with amenorrhea. Elevation of serum human chorionic gonadotropin (hCG) was seen in four cases. Pathologically, the tumor involved endocervix in three cases and involved uterine corpus in another two. All five tumors were invasive, nodular lesions consisting of epithelioid intermediate trophoblastic cells that were mononuclear with abundant eosinophilic cytoplasm, along with zones of hyaline material and necrotic debris. In three cases of cervical involvement, the neoplastic cells focally replaced endocervical surface and glandular epithelium, simulating high-grade squamous intraepithelial lesions. Immunohistochemically, all five tumors displayed focal positivity for human placental lactogen and hCG. Positive nuclear staining of p63 was seen in all five cases. All patients received total hysterectomy and various regimes of adjuvant chemotherapy. Three patients survived the tumor with no recurrences or metastases with follow-up periods of 3, 7 and 16 years. One patient is currently alive with lung metastasis 1 month after the surgery. One patient died of tumor metastasis 8 months after the diagnosis. In summary, with its unusual ability to simulate an invasive squamous cell carcinoma and other epithelioid neoplasms, epithelioid trophoblastic tumor frequently poses a diagnostic challenge, especially when involving the uterine cervix. High index of suspicion and an awareness of elevation of serum chorionic gonadotropin are crucial in reaching a correct diagnosis.  相似文献   
73.
Unsharp masking is a widely used image-enhancement method in medical imaging. Hardware-based solutions can be developed to support high computational demand for unsharp masking, but they suffer from limited flexibility. Software solutions can easily incorporate new features and modify key parameters, such as filtering kernel size, but they have not been able to meet the fast computing requirement. Modern programmable mediaprocessors can meet both fast computing and flexibility requirements, which will benefit medical image computing. In this article, we present fast adaptive unsharp masking on two leading mediaprocessors or high-end digital signal processors, Hitachi/Equator Technologies MAP-CA and Texas Instruments TMS320C64x. For a 2k × 2k 16-bit image, our adaptive unsharp masking with a 201 × 201 boxcar kernel takes 225 ms on a 300-MHz MAP-CA and 74 ms on a 600-MHz TMS320C64x. This fast unsharp masking enables technologists and/or physicians to adjust parameters interactively for optimal quality assurance and image viewing.  相似文献   
74.
The molecular basis underlying the development and progression of gallbladder carcinoma (GBC) remains poorly understood. To evaluate the roles of p21(WAF1/CIP1) and p53 in gallbladder carcinogenesis and to assess their prognostic significance for patients with GBC, we used immunohistochemistry to examine the expression of p21(WAF1/CIP1) and p53 protein in a series of surgically resected specimens, including normal epithelia, precancerous lesions adenoma, and dysplasia, and carcinomas of the gallbladder. Reduced p21(WAF1/CIP1) expression was frequently observed in carcinomas (18 of 37 lesions; 49%), and even in precancerous lesions adenomas (3 of 7; 43%) and dysplasias (5 of 5; 100%). p53 overexpression was detected in 43% of the adenomas, 60% of the dysplasias and 57% of the carcinomas. There was an inverse relationship between p21(WAF1/CIP1) and p53 expression in GBCs (P =.01). Survival analysis indicated that reduced p21(WAF1/CIP1) expression was significantly associated with shortened disease-free and overall survival (P =.04 and.03, respectively) for patients with stages II to IV GBCs. These observations suggest that reduced p21(WAF1/CIP1) expression and p53 overexpression contribute to GBC from an early stage and that determination of p21(WAF1/CIP1) expression in surgically resected specimens would add prognostic information to conventional pathologic examinations for patients with advanced-stage GBC.  相似文献   
75.
目的 探讨各种细胞因子对T细胞生长激素(GH)基因表达的影响。方法 构建含人GH调控序列的荧光素酶报告基因质粒pGL2-GH-luc,然后转染入T淋巴细胞系Jurkat E6-1细胞中,在培养液中分别加入各种细胞因子。结果 生理浓度的IL-1β,TNF-β和IFN-γ,对Jurkat细胞中荧光素酶的表达具有抑制作用(P<0.05)。结论 细胞因子参与了调节淋巴细胞GH基因的表达。  相似文献   
76.
Co-infection with hepatitis B virus (HBV) and hepatitis C Virus (HCV) is associated with increased frequency in the development of hepatocellular carcinoma (HCC). Here, we demonstrated that HBV X protein (HBx) and HCV core cooperate to transform mouse fibroblast NIH3T3 cells. They additively stimulated cell growth, especially in the absence of serum growth factors. In addition, co-expression of HBx and HCV core had additive effects on the induction of anchorage-independent cell growth as well as on the secretion of matrix metalloproteases, which may contribute to increased metastatic potential. Furthermore, the cells expressing both viral proteins exhibited higher tumorigenicity, as demonstrated in athymic nude mice.  相似文献   
77.
PurposeDissection after plain balloon angioplasty is required to achieve adequate luminal area; however, it is associated with a high risk of vascular events. This study aimed to examine the relationship between non-flow limiting coronary dissections and subsequent lumen loss and long-term clinical outcomes following successful drug-coated balloon (DCB) treatment of de novo coronary lesions.Materials and MethodsA total of 227 patients with good distal flow (Thrombolysis in Myocardial Infarction flow grade 3) following DCB treatment were retrospectively enrolled and stratified according to the presence or absence of a non-flow limiting dissection. The primary endpoint was late lumen loss (LLL) at 6-month angiography, and the secondary endpoint was target vessel failure (TVF, a composite of cardiac death, target vessel myocardial infarction, target vessel revascularization, and target vessel thrombosis).ResultsThe cohort consisted of 95 patients with and 132 patients without a dissection. There were no between-group differences in LLL (90.8%) returning for angiography at 6 months (0.05±0.19 mm in non-dissection and 0.05±0.30 mm in dissection group, p=0.886) or in TVF (6.8% in non-dissection and 8.4% in dissection group, p=0.799) at a median follow-up of 3.4 years. In a multivariate analysis, the presence of dissection and its severity were not associated with LLL or TVF. Almost dissections (93.9%) were completely healed, and there was no newly developed dissection at 6-month angiography.ConclusionThe presence of a dissection following successful DCB treatment of a de novo coronary lesion may not be associated with an increased risk of LLL or TVF (Impact of Drug-coated Balloon Treatment in de Novo Coronary Lesion; NCT04619277).  相似文献   
78.
Mouse monoclonal antibodies to Hepatitis B surface antigen(HBsAg) were prepared and their functional capabilities tested by the method of solid phase enzyme linked immuno sorbent assay(ELISA). HBsAg binding studies indicated that one monoclonal antibody 6E-1-1 bound more HBsAg at a faster rate than the other monoclonal antibodies. Also, for the binding inhibition studies with the selected monoclonal antibody 6E-1-1, one monoclonal antibody 8D-3-6 didn’t exhibit binding inhibition for HBsAg. Then, a simultaneous ELISA method was developed for the immunodiagnosis of HBsAg. Different combinations of two monoclonal antibodies as solid phase and horseradish peroxidase(HRPO) labeled phase were studied. The combination of monoclonal antibody of higher affinity constant (6E-1-1) immobilized in a solid phase and monoclonal antibody of lower affinity constant (8D-3-6) as a HRPO labeled phase was more sensitive when two monoclonal antibodies of different affinity constants for HBsAg were prepared.  相似文献   
79.
目的 了解肾综合症出血热(HFRS)各期血清蛋白的变化特点及其与肝、肾功能的关系。方法 采用瑞士产COBAS MIRA PLUS CC全血动生化分析仪及日本产MA-4210尿液分析仪分别检测同时的空腹静脉血及晨尿。结果 150例HFRS患者217次检测血清总蛋白(T)平均为63.51g/L,白蛋白(A)为36.29g/L,球蛋白(G)为27.22g/L,A/G=1.33。其中A/G为1.49-1.0者137例(63.3%),A/G<1.0者27例(12.44%),A/G≥1.5者53例(24.42%)。结论 HFRS患者有75.58%存在着低白蛋白血症,并贯穿于各期,异常程度与病情轻重呈正相关,主要原因是肾脏损害,大量白蛋白从尿中丢失,与肝脏的合成功能关系不大。  相似文献   
80.
东方田鼠室内繁殖与生长发育观察   总被引:2,自引:1,他引:1  
近年来,逐渐增多的小鼠突变系资源已对现有的动物设施和品种(系)的保存方法提出严峻的挑战,小鼠胚胎和配合子的低温保存是目前保存小鼠种群资源中应用最为广泛的方法,通过低温保存不仅使原有的或新开发的小鼠品系得以安全的,长期的保存下来,同时也使这些小 模型的规模化生产,推广普及变得更为简单化,无疑,小鼠模型的保存将为21世纪哺乳类遗传学的飞速发展和最终攻克人类目前的疑难疾病创造了有利条件。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号